Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 07, 2024
Governor Josh Shapiro announced the Commonwealth is investing nearly $3 million in Adare Pharma Solutions to support the life sciences company’s growth and headquarters relocation to Pennsylvania from New Jersey. Within three years, Adare’s $16.8 ...
read more
Wednesday, August 07, 2024
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has entered into a License Agreement with the Broad Institute to expand its AAV Curator™ Platform offering to include MyoAAV plasmids.
read more
Asymchem Laboratories announced that it has officially inaugurated its new European development and pilot manufacturing site at Discovery Park in Sandwich, Kent, U.K., marked with a ribbon cutting by Dr. Hao Hong, Chairman, Founder, and CEO of ...
read more
Lonza announced the addition of clinical bottling and labeling capabilities at its Small Molecules site in Bend, Oregon (US). Building upon the recent investment in the dedicated early-phase clinical manufacturing facility, the offering now includes ...
read more
Cresset, a provider of integrated in silico solutions for drug discovery, announced an extension of the global collaboration with Enamine, a chemical and biological contract research organization and producer of novel building blocks for drug design,...
read more
Thursday, August 01, 2024
WuXi Biologics announced that four manufacturing facilities and Suzhou Biosafety Testing Center in China have received Good Manufacturing Practice (GMP) certificates from the European Medicines Agency (EMA), demonstrating the company's commitment to ...
read more
Eximia Research announced the integration of Tidewater Clinical Research into its national network of clinical trial sites. This strategic development unites Tidewater's longstanding expertise in Women's Health and Ophthalmology with Eximia's ...
read more
Zealand Pharma A/S, a biotechnology company focused on the discovery and development of innovative peptide-based medicines, today announced the appointment of Eric Cox as Zealand’s Chief Commercial Officer starting August 5, 2024. Eric will join the ...
read more
ACG Packaging Materials, a division of ACG - the world's only integrated pharmaceutical solutions and manufacturing company, has been honoured with a Kepner-Tregoe (KT) Excellence Award in the team category for problem-solving excellence.
read more
Almac Clinical Services has announced a significant investment to develop a new frozen facility in Singapore which will quadruple the existing facility’s floorspace and providing an additional 480 storage locations.
read more
Currax Pharmaceuticals LLC announced the approval of additional manufacturing site for CONTRAVE®/MYSIMBA® in the European Union (EU) and European Union Economic Areas (EEA).
read more
Almac Pharma Services announced the successful completion of its first FDA inspection of its commercial manufacturing facility in Charnwood, England.
read more
Alcami Corporation has announced significantly expanded cold, stability, and custom storage options at its new 65,000 ft2 state-of-the-art pharma storage facility in Garner. With a prime location near the Research Triangle Park (RTP) biotech and ...
read more
Emmes Group, a specialty tech-enabled global contract research organization (CRO), announced a multi-year strategic partnership with Miimansa AI. A critical part of the partnership, aimed at revolutionizing clinical research at Emmes, is the ...
read more
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925 million.
read more